Objectives Metabolic syndrome is a cluster of risk factors for type 2 diabetes mellitus and cardiovascular disease. Associations between metabolic syndrome and several types of cancer have recently been documented.
Methods We analyzed the sample cohort data from the Korean National Health Insurance Service from 2002, with a follow-up period extending to 2013. The cohort data included 99 565 individuals who participated in the health examination program and whose data were therefore present in the cohort database. The metabolic risk profile of each participant was assessed based on obesity, high serum glucose and total cholesterol levels, and high blood pressure. The occurrence of cancer was identified using Korean National Health Insurance claims data. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusting for age group, smoking status, alcohol intake, and regular exercise.
Results A total of 5937 cases of cancer occurred during a mean follow-up period of 10.4 years. In men with a high-risk metabolic profile, the risk of colon cancer was elevated (HR, 1.40; 95% CI, 1.14 to 1.71). In women, a high-risk metabolic profile was associated with a significantly increased risk of gallbladder and biliary tract cancer (HR, 2.05; 95% CI, 1.24 to 3.42). Non-significantly increased risks were observed in men for pharynx, larynx, rectum, and kidney cancer, and in women for colon, liver, breast, and ovarian cancer.
Conclusions The findings of this study support the previously suggested association between metabolic syndrome and the risk of several cancers. A high-risk metabolic profile may be an important risk factor for colon cancer in Korean men and gallbladder and biliary tract cancer in Korean women.
Summary
Citations
Citations to this article as recorded by
Association of Metabolic Syndrome With Risk of Lung Cancer Mengmeng Li, Su-Mei Cao, Niki Dimou, Lan Wu, Ji-Bin Li, Jun Yang CHEST.2024; 165(1): 213. CrossRef
Association between insulin resistance, metabolic syndrome and its components and lung cancer: a systematic review and meta-analysis Jingxuan Liu, Rui Wang, Song Tan, Xiaohu Zhao, Aihua Hou Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
Association between metabolic syndrome and kidney cancer risk: a prospective cohort study Lin Wang, Han Du, Chao Sheng, Hongji Dai, Kexin Chen Lipids in Health and Disease.2024;[Epub] CrossRef
Interplay of Cardiometabolic Syndrome and Biliary Tract Cancer: A Comprehensive Analysis with Gender-Specific Insights Vincenza Di Stasi, Antonella Contaldo, Lucia Birtolo, Endrit Shahini Cancers.2024; 16(19): 3432. CrossRef
Survival benefit of metformin use according to cancer diagnosis in diabetic patients with metabolic syndrome Ji Soo Park, Soo Jin Moon, Hyung Seok Park, Sang-Hoon Cho Preventive Medicine Reports.2024; 48: 102928. CrossRef
Metabolic syndrome and risk of ovarian cancer: a systematic review and meta-analysis Ziyu Chen, Zesi Liu, Hongxia Yang, Chaosheng Liu, Fandou Kong Frontiers in Endocrinology.2023;[Epub] CrossRef
Updated epidemiology of gastrointestinal cancers in East Asia Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong Nature Reviews Gastroenterology & Hepatology.2023; 20(5): 271. CrossRef
Association of metabolic syndrome and its components with the risk of kidney cancer: A cohort-based case-control study Runxue Jiang, Zhi Li, Xia Wang, Haifeng Cai, Shouling Wu, Shuohua Chen, Hailong Hu Technology and Health Care.2023; 31(4): 1235. CrossRef
Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study Dan Huang, Woo-Kyoung Shin, Katherine De la Torre, Hwi-Won Lee, Sukhong Min, Aesun Shin, Jong-Koo Lee, Daehee Kang Gastric Cancer.2023; 26(4): 481. CrossRef
Association Between Metabolic Syndrome and the Risk of Lung Cancer: A
Meta-Analysis Zhao Zhang, Qinxiang Liu, Congcong Huang, Jun Wu, Yingsheng Wen Hormone and Metabolic Research.2023; 55(12): 846. CrossRef
The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study Yu-Guang Chen, Chih-Wei Yang, Chi-Hsiang Chung, Ching-Liang Ho, Wei-Liang Chen, Wu-Chien Chien Hepatology International.2022; 16(4): 807. CrossRef
The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu Frontiers in Oncology.2022;[Epub] CrossRef
Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis Morgan Connaughton, Mahsa Dabagh Healthcare.2022; 10(6): 1074. CrossRef
Association Between Metabolic Syndrome and Risk of Renal Cell Cancer: A Meta-Analysis Wurong Du, Kaibo Guo, Huimin Jin, Leitao Sun, Shanming Ruan, Qiaoling Song Frontiers in Oncology.2022;[Epub] CrossRef
The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study Seong-geun Moon, Boyoung Park Journal of Preventive Medicine and Public Health.2022; 55(5): 475. CrossRef
The association between hypertension and colorectal cancer: a meta-analysis of observational studies Kun Xuan, Tianming Zhao, Chenyu Sun, Akash S. Patel, Haixia Liu, Xin Chen, Guangbo Qu, Yehuan Sun European Journal of Cancer Prevention.2021; 30(1): 84. CrossRef
Metabolic syndrome and esophageal cancer risk: a systematic review and meta‑analysis Jinjia Zhang, Huadong Wu, Rongying Wang Diabetology & Metabolic Syndrome.2021;[Epub] CrossRef
Metabolic syndrome and gastric cancer risk: a systematic review and meta-analysis Marco Mariani, Michele Sassano, Stefania Boccia European Journal of Cancer Prevention.2021; 30(3): 239. CrossRef
Persistent status of metabolic syndrome and risk of cholangiocarcinoma: A Korean nationwide population-based cohort study Joo-Hyun Park, Jung Y. Hong, Young S. Park, Gunseog Kang, Kyungdo Han, Joon O. Park European Journal of Cancer.2021; 155: 97. CrossRef
Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis Xiaoding Shen, Yong Wang, Rui Zhao, Qianyi Wan, Yutao Wu, Lihao Zhao, Xiaoting Wu International Journal of Colorectal Disease.2021; 36(10): 2215. CrossRef
Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study Bin Xia, Jianjun Peng, De Toni Enrico, Kuiqing Lu, Eddie C. Cheung, Zichong Kuo, Qiangsheng He, Yan Tang, Anran Liu, Die Fan, Changhua Zhang, Yulong He, Yihang Pan, Jinqiu Yuan BMC Cancer.2021;[Epub] CrossRef
Association between Abdominal Obesity and Incident Colorectal Cancer: A Nationwide Cohort Study in Korea Ga Eun Nam, Se-Jin Baek, Hong Bae Choi, Kyungdo Han, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim Cancers.2020; 12(6): 1368. CrossRef
Metabolic Syndrome and Risk of Lung Cancer: An Analysis of Korean National Health Insurance Corporation Database Sooim Sin, Chang-Hoon Lee, Sun Mi Choi, Kyung-Do Han, Jinwoo Lee The Journal of Clinical Endocrinology & Metabolism.2020; 105(11): e4102. CrossRef
Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies Li Qiao, Deliang Ma, Hui Lv, Ding Shi, Min Fei, Yu Chen, Fei Xie, Zhuoyan Wang, Ying Wang, Wanhua Liang, Peiying Hu Diabetology & Metabolic Syndrome.2020;[Epub] CrossRef
Metabolic Syndrome and Colorectal Cancer Risk: Results of Propensity Score-Based Analyses in a Community-Based Cohort Study Jinsun Kim, Eun Young Park, Eunjung Park, Min Kyung Lim, Jin-Kyoung Oh, Byungmi Kim International Journal of Environmental Research and Public Health.2020; 17(22): 8687. CrossRef
The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis Ping Zhao, Ning Xia, Hong Zhang, Tingting Deng Obesity Facts.2020; 13(4): 384. CrossRef
Metabolic syndrome and liver-related events: a systematic review and meta-analysis Huina Ren, Junna Wang, Yue Gao, Fuwei Yang, Wenxiang Huang BMC Endocrine Disorders.2019;[Epub] CrossRef
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies Aristeidis Seretis, Sofia Cividini, Georgios Markozannes, Xanthippi Tseretopoulou, David S. Lopez, Evangelia E. Ntzani, Konstantinos K. Tsilidis Scientific Reports.2019;[Epub] CrossRef
Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER–Medicare data Kara A. Michels, Timothy S. McNeel, Britton Trabert Gynecologic Oncology.2019; 155(2): 294. CrossRef
Association between metabolic syndrome and the incidence of gastric cancer: a meta-analysis of cohort studies Zhibin Li, Hongfeng Han, Yuan Chang Diabetology & Metabolic Syndrome.2019;[Epub] CrossRef
Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies Meng Guo, Tingting Liu, Peiting Li, Tianying Wang, Chen Zeng, Meng Yang, Gang Li, Jiang Han, Wei Wu, Ruopeng Zhang Frontiers in Oncology.2019;[Epub] CrossRef
Incidence of Colon Cancer Related to Cigarette Smoking and Alcohol Consumption in Adults with Metabolic Syndrome: Prospective Cohort Study Ahra Jo, Heeyoung Oh Journal of Korean Academy of Nursing.2019; 49(6): 713. CrossRef
Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors) Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas'ev, Alena L. Chernyshova, Igor V. Kudryavtsev, Anastasia A. Tsydenova Asia-Pacific Journal of Clinical Oncology.2018; 14(3): 134. CrossRef
Incidence and risk factors of colorectal cancer based on 56 324 health checkups: A 7‐year retrospective cohort study Toshiko Fujii, Masayuki Ohisa, Toru Sako, Takayuki Harakawa, Kazuaki Sakamune, Shintaro Nagashima, Aya Sugiyama, Yuichiro Matsuura, Junko Tanaka Journal of Gastroenterology and Hepatology.2018; 33(4): 855. CrossRef
The role of metabolic syndrome variant in the malignant tumors progression Natalia V. Yunusova, Irina V. Kondakova, Larisa A. Kolomiets, Sergey G. Afanas’ev, Anastasia Yu. Kishkina, Liudmila V. Spirina Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2018; 12(5): 807. CrossRef
Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients Alban Zarzavadjian Le Bian, Christine Denet, Nicolas Tabchouri, Gianfranco Donatelli, Philippe Wind, Christophe Louvet, Mostefa Bennamoun, Christos Christidis, Thierry Perniceni, David Fuks, Brice Gayet Langenbeck's Archives of Surgery.2018; 403(4): 443. CrossRef
Effect of Work-Related Sedentary Time on Overall Health Profile in Active vs. Inactive Office Workers Pauline M. Genin, Pascal Dessenne, Julien Finaud, Bruno Pereira, Frederic Dutheil, David Thivel, Martine Duclos Frontiers in Public Health.2018;[Epub] CrossRef
A Case of Endoscopic Submucosal Dissection of Esophageal Adenocarcinoma Arising from Barrett's Esophagus Joon Sung Kim, Byung-Wook Kim The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(3): 169. CrossRef
Objectives The goal of this study was to identify association between the continuity of ambulatory care of diabetes patients in South Korea (hereafter Korea) and the incidence of macrovascular complications of diabetes, using claims data compiled by the National Health Insurance Services of Korea.
Methods This study was conducted retrospectively. The subjects of the study were 43 002 patients diagnosed with diabetes in 2007, who were over 30 years of age, and had insurance claim data from 2008. The macrovascular complications of diabetes mellitus were limited to ischemic heart disease and ischemic stroke. We compared the characteristics of the patients in whom macrovascular complications occurred from 2009 to 2012 to the characteristics of the patients who had no such complications. Multiple logistic regression was used to assess the effects of continuity of ambulatory care on diabetic macrovascular complications. The continuity of ambulatory diabetes care was estimated by metrics such as the medication possession ratio, the quarterly continuity of care and the number of clinics that were visited.
Results Patients with macrovascular complications showed statistically significant differences regarding sex, age, comorbidities, hypertension, dyslipidemia and continuity of ambulatory diabetes care. Visiting a lower number of clinics reduced the odds ratio for macrovascular complications of diabetes. A medication possession ratio below 80% was associated with an increased odds ratio for macrovascular complications, but this result was of borderline statistical significance.
Conclusions Diabetes care by regular health care providers was found to be associated with a lower occurrence of diabetic macrovascular complications. This result has policy implications for the Korean health care system, in which the delivery system does not work properly.
Summary
Citations
Citations to this article as recorded by
Chasms in Achievement of Recommended Diabetes Care among Geographic Regions in Korea Sanghyun Cho, Ji-Yeon Shin, Hyun Joo Kim, Sang Jun Eun, Sungchan Kang, Won Mo Jang, Hyemin Jung, Yoon Kim, Jin Yong Lee Journal of Korean Medical Science.2019;[Epub] CrossRef
Objectives Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea.
Methods We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death.
Results In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively.
Conclusions We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
Summary
Citations
Citations to this article as recorded by
Longitudinal economic burden of incident complications among metabolic syndrome populations Kah Suan Chong, Yi-Hsin Chang, Chun-Ting Yang, Chu-Kuang Chou, Huang‑Tz Ou, Shihchen Kuo Cardiovascular Diabetology.2024;[Epub] CrossRef
Machine Learning-Driven Metabolic Syndrome Prediction: An International Cohort Validation Study Zhao Li, Wenzhong Wu, Hyunsik Kang Healthcare.2024; 12(24): 2527. CrossRef
Predicting Habitual Use of Wearable Health Devices Among Middle-aged Individuals With Metabolic Syndrome Risk Factors in South Korea: Cross-sectional Study Jaeyoung Ha, Jungmi Park, Sangyi Lee, Jeong Lee, Jin-Young Choi, Junhyoung Kim, Sung-il Cho, Gyeong-Suk Jeon JMIR Formative Research.2023; 7: e42087. CrossRef
Tools to assess employment readiness for colorectal cancer survivors: A scoping review Mingshuang Ding, Elise Gane, Harry Wiffen, Venerina Johnston Cancer Medicine.2023; 12(17): 18327. CrossRef
Prevalence of Metabolic Syndrome and Its Association with Sociodemographic Characteristics in Participants of a Public Chronic Disease Control Program in Medellin, Colombia, in 2018
Luis Felipe Higuita-Gutiérrez, Wilson de Jesús Martínez Quiroz, Jaiberth Antonio Cardona-Arias Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 1161. CrossRef
Cross-sectional study of the prevalence and risk factors of metabolic syndrome in a rural population of the Qianjiang area Bing Ling, Li Zhao, Jixiu Yi Medicine.2020; 99(35): e21574. CrossRef
The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study Thi Xuan Trinh Nguyen, Minji Han, Moran Ki, Young Ae Kim, Jin-Kyoung Oh International Journal of Environmental Research and Public Health.2020; 17(20): 7592. CrossRef
The economic burden of cancers attributable to smoking
in Korea, 2014 Thi Nguyen, Minji Han, Jin-Kyoung Oh Tobacco Induced Diseases.2019;[Epub] CrossRef
The economic burden of cancer attributable to obesity in Korea: A population‐based cohort study Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun‐Cheol Park European Journal of Cancer Care.2019;[Epub] CrossRef
The Prevalence of Metabolic Syndrome and Its Related Risk Complications among Koreans Seung-Hoo Lee, Shuting Tao, Hak-Seon Kim Nutrients.2019; 11(8): 1755. CrossRef
Association between Low-Intensity Smoking and Metabolic Syndrome in Korean Men Minji Park, Seran Min, Yu Jin Cho, Sunwoo Kim, Hyuktae Kwon, Hee-Kyung Joh, Bumjo Oh, Seung-Won Oh, Ho Chun Choi, Cheol Min Lee Journal of the Korean Society for Research on Nicotine and Tobacco.2019; 10(2): 89. CrossRef
Toenail Chromium Concentration and Metabolic Syndrome among Korean Adults Jakyung Son, J. Steven Morris, Kyong Park International Journal of Environmental Research and Public Health.2018; 15(4): 682. CrossRef
The prevalence trend of metabolic syndrome and its components and risk factors in Korean adults: results from the Korean National Health and Nutrition Examination Survey 2008–2013 Binh Thang Tran, Bo Yoon Jeong, Jin-Kyoung Oh BMC Public Health.2017;[Epub] CrossRef
The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort Study Bang Wool Eom, Young-Woo Kim, Byung-Ho Nam, Keun Won Ryu, Hyun-Yong Jeong, Young-Kyu Park, Young-Joon Lee, Han-Kwang Yang, Wansik Yu, Jeong-Hwan Yook, Geun Am Song, Sei-Jin Youn, Heung Up Kim, Sung-Hoon Noh, Sung Bae Park, Doo-Hyun Yang, Sung Kim Journal of Gastric Cancer.2016; 16(3): 182. CrossRef